Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey

Modern surgical oncology is increasingly moving towards tissue-preserving strategies over radical approaches in the vast majority of malignancies, provided that such approaches are technically feasible and oncologically effective [1 –4]. Whilst there is some interest in such a concept for prostate cancer (PCa), the prostate does still remain the last solid organ for which whole-gland treatments are carried out as standard of care. It is indeed an exception to treat in the same manner men harbouring measurable disease ranging from high volume low-risk to high-risk disease.

Source: Urologic Oncology: Seminars and Original Investigations - October 6, 2018 Category: Urology & Nephrology Authors: Giancarlo Marra, Guillaume Ploussard, Piet Ost, Pieter J.L. De Visschere, Alberto Briganti, Giorgio Gandaglia, Derya Tilki, Christian I. Surcel, Igor Tsaur, Roderick C.N. Van Den Bergh, Alexander Kretschmer, Hendrik Borgmann, Paolo Gontero, Hashim U. Ahme Tags: Original article Source Type: research